MiRNA-200b reverses drug resistance of hepatocellular carcinoma HepG2 cells to sorafenib and its underlying mechanism

Objective To explore the effect of miRNA-200b on sorafenib resistance in hepatocellular carcinoma cells in order to increase the efficacy of the drug in advanced liver cancer patients. Methods Sorafenib resistant hepatocellular carcinoma HepG2-SR cell line was established by gradually increasing th...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: DENG Yong, TANG Tengqian, ZHANG Leida
Format: article
Langue:ZH
Publié: Editorial Office of Journal of Third Military Medical University 2021
Sujets:
Accès en ligne:https://doaj.org/article/ebebf18ffa6548c1a4574feac02cd3e2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!